FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations.

about

Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.Progression inference for somatic mutations in cancer.Core signaling pathways in ovarian cancer stem cell revealed by integrative analysis of multi-marker genomics data.

P2860

Q37735635-C3E08A7E-3176-431D-9142-3841B04AF1C1 Q38793244-C2C35A5A-3F2F-4BDB-9990-03F2BEDFC830 Q55520593-F98DB749-2622-4E82-BB9E-61D5328D501E

P2860

FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations.

Item

http://www.wikidata.org/entity/Q36746291

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

FOXA1 expression affects the p ...... cancer stem cell populations.

@en

type

Item

label

FOXA1 expression affects the p ...... cancer stem cell populations.

@en

prefLabel

FOXA1 expression affects the p ...... cancer stem cell populations.

@en

P1476

FOXA1 expression affects the p ...... cancer stem cell populations.

@en

P2093

Akira Shiraishi

http://www.w3.org/2001/XMLSchema#string

Hiroko Bando

http://www.w3.org/2001/XMLSchema#string

Hisato Hara

http://www.w3.org/2001/XMLSchema#string

Ikki Tsuboi

http://www.w3.org/2001/XMLSchema#string

Kana Tachi

http://www.w3.org/2001/XMLSchema#string

Osamu Ohneda

http://www.w3.org/2001/XMLSchema#string

Toshiharu Yamashita

http://www.w3.org/2001/XMLSchema#string

Toshiki Kato

http://www.w3.org/2001/XMLSchema#string

P2860

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer

FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis

GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

Molecular portraits of human breast tumours

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

P304

281-289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.12870

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26708273

http://www.w3.org/2001/XMLSchema#string

P932

4814260

http://www.w3.org/2001/XMLSchema#string

FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations.

about

P2860

P2860

FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932